GR20030100286A - Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεις - Google Patents

Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεις

Info

Publication number
GR20030100286A
GR20030100286A GR20030100286A GR2003100286A GR20030100286A GR 20030100286 A GR20030100286 A GR 20030100286A GR 20030100286 A GR20030100286 A GR 20030100286A GR 2003100286 A GR2003100286 A GR 2003100286A GR 20030100286 A GR20030100286 A GR 20030100286A
Authority
GR
Greece
Prior art keywords
pregnancy
pregnant women
pharmaceutical dosage
friendly
apt
Prior art date
Application number
GR20030100286A
Other languages
English (en)
Other versions
GR1004641B (el
Inventor
Gervais�Eric�
Atanackovic�Gordana�
Hebert�Raymond�
Original Assignee
Duchesnay�Inc@��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duchesnay�Inc@�� filed Critical Duchesnay�Inc@��
Publication of GR20030100286A publication Critical patent/GR20030100286A/el
Publication of GR1004641B publication Critical patent/GR1004641B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ίαΑμορφήΑφαρμακευτικήςΑδοσολογίαςΑπουΑπεριλαμβα΄νειΑτουλάχιστονΑέναΑεεργόΑσυστατικόΑκαιΑπρορίζεταιΑγιαΑχορήγησηΑσεΑέγκυεςΑγυναίκες@ΑΗΑμορφήΑφαρμακευτικήςΑδοσολογίαςΑφέρειΑφιλικέςΑπροςΑτηνΑκύησηΑενδείξειςΑπουΑμπορούνΑναΑβελτιώσεουνΑτηΑσυμμόρφωσηΑτωνασθενώνΑμεΑιατρικάΑσυνιστώμενεςΑμορφέςΑθεραπευτικήςΑαγωγήςΑμεΑφάρμακαΑπουΑοδηγούνΑσεΑβελτιωμένηΑαποτελεσματικότηταΑτωνΑπροϊόντων@ΑΟιΑφιλικεςΑπροςΑτηνΑκύησηΑενδείξειςςΑμπορείΑναΑμειώνουνΑταΑσυμβάνταΑεσφαλμένηςΑδιανομήςΑήΑεσφαλμένηςΑαπορροφήσεωςΑμορφώνΑφαρμακευτικήςΑδοσολογίαςΑπουΑδενΑπροορίζονταιΑγιαΑέγκυεςΑγυναίκες@ΑΕπίσηςΑαποκαλύπτεταιΑμίαΑμέθοδοςΑγιαΑτηΑμείωσηΑτωνΑσυμβαντωνΑεσφαλμένηςΑδιανομήςΑήΑεσφαλμένηςΑαπορροφήσεωςΑμορφώνΑδοσολογίαςΑπουΑδενΑπροορίζονταιΑγιαΑεέγκυεςΑγυναίκες@ΑΟιΑενΑλόγωΑμέθοδοιΑπεριλαμβανουνΑτηνΑπαροχήΑμιαςΑμορφήςΑφαρμακευτικήςΑδοσολογίαςΑπουΑπροορίζεταιΑγιαΑχρήσηΑαπόΑέγκυεςΑγυναίκεςΑηΑοποίαΑφέρειΑφιλικέςΑπροςΑτηνΑκύησηΑενδείξειςΑπουΑμπορούνΑναΑδιακρίνουνΑγραφικώςΑτιςΑμορφέςΑδοσολογίαςΑοιΑοποίεςΑπροορίζονταιΑγιαΑχρήσηΑκατάΑτηνΑκύησηΑαπόΑτιςΑάλλες@ΑΑΑΰ
GR20030100286A 2002-07-05 2003-07-02 Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα GR1004641B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002392486A CA2392486A1 (en) 2002-07-05 2002-07-05 Pharmaceutical dosage form bearing pregnancy-friendly indicia

Publications (2)

Publication Number Publication Date
GR20030100286A true GR20030100286A (el) 2004-03-19
GR1004641B GR1004641B (el) 2004-07-23

Family

ID=4171184

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20030100286A GR1004641B (el) 2002-07-05 2003-07-02 Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα

Country Status (12)

Country Link
US (3) US7560122B2 (el)
AU (1) AU2003245774A1 (el)
BE (1) BE1016043A5 (el)
CA (1) CA2392486A1 (el)
FR (1) FR2841783A1 (el)
GR (1) GR1004641B (el)
IE (1) IE20030484A1 (el)
IT (1) ITUD20030145A1 (el)
MC (1) MC200066A1 (el)
NL (1) NL1023797C2 (el)
TW (1) TW200400835A (el)
WO (1) WO2004004694A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
JP5914701B2 (ja) 2012-02-22 2016-05-11 デュシネイ・インコーポレイテッド ドキシラミンおよびピリドキシン、ならびに／またはその代謝物もしくは塩の製剤
USD711616S1 (en) * 2012-10-02 2014-08-26 Shylaja Balagopal Set of yoga pose chocolates
PL3024466T3 (pl) 2013-07-22 2018-08-31 Duchesnay Inc. Kompozycja do kontrolowania nudności i wymiotów
EP3337480A4 (en) * 2015-08-17 2019-05-08 Aequus Pharmaceuticals Inc. TRANSDERMAL ADMINISTRATION OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
AR121619A1 (es) * 2020-03-25 2022-06-22 Inibsa Ginecologia S A Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778984A (en) * 1985-10-16 1988-10-18 Canon Denshi Kabushiki Kaisha Apparatus for detecting focus from astigmatism
US4788984A (en) 1987-01-30 1988-12-06 Procare Industries Ltd. Method and kit for use in conceiving a child of a desired gender
US5290799A (en) 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ES2149767T5 (es) 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.
CA2081679A1 (en) 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5457895A (en) * 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5443288A (en) * 1994-07-25 1995-08-22 Miles; Barbara L. Pregnancy advent calendar
US5531230A (en) * 1995-07-14 1996-07-02 Bell; Ray W. Strap secured condom
AU735071B2 (en) * 1996-06-17 2001-06-28 Janssen Pharmaceutica N.V. Marking rapidly disintegrating dosage forms
US6226564B1 (en) * 1996-11-01 2001-05-01 John C. Stuart Method and apparatus for dispensing drugs to prevent inadvertent administration of incorrect drug to patient
US5836890A (en) * 1997-05-30 1998-11-17 Joseph N. Jackson Apparatus and method of providing a personal fertility predictor
UA57811C2 (uk) 1997-11-21 2003-07-15 Пфайзер Продактс Інк. Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності
KR20060085258A (ko) 1998-02-24 2006-07-26 웨이크 포리스트 유니버시티 만성 통증 및 여성에 특유한 통증을 비롯한 통증의 치료방법
DE69912379T2 (de) 1998-08-14 2004-05-06 Pfizer Inc. Antithrombosemittel
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US6223559B1 (en) * 1999-07-20 2001-05-01 Shelia J. Coleman Medical identification charm bracelet
EP1149572B1 (en) * 2000-04-26 2005-03-02 Shin-Etsu Chemical Co., Ltd. Solid preparation coated with a film coating layer having two or more different colors
US6701035B2 (en) * 2000-12-14 2004-03-02 Hewlett-Packard Development Company, L.P. Electric-field actuated chromogenic materials based on molecules with a rotating middle segment for applications in photonic switching
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA103771S (en) * 2003-07-22 2006-01-18 Duchesnay Inc Pharmaceutical dosage form

Also Published As

Publication number Publication date
IE20030484A1 (en) 2004-01-14
US20110059026A1 (en) 2011-03-10
FR2841783A1 (fr) 2004-01-09
NL1023797A1 (nl) 2004-01-06
ITUD20030145A1 (it) 2004-01-06
TW200400835A (en) 2004-01-16
AU2003245774A1 (en) 2004-01-23
NL1023797C2 (nl) 2004-03-10
CA2392486A1 (en) 2002-12-08
BE1016043A5 (fr) 2006-02-07
US20040091526A1 (en) 2004-05-13
US20060159750A1 (en) 2006-07-20
US7560122B2 (en) 2009-07-14
MC200066A1 (fr) 2004-03-03
GR1004641B (el) 2004-07-23
WO2004004694A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
Stewart et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial
Chapman et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day− 1) in the treatment of cutaneous or lymphocutaneous sporotrichosis
EP2248519A3 (en) Non-mucoadhesive film dosage forms
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
MXPA05007158A (es) Formulacion farmaceutica con un agente activo insoluble.
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
AR018410A1 (es) Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron
RU2010105123A (ru) Композиции для ухода за полостью рта, продукты и способы применения
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
SG146638A1 (en) Pharmaceutical delivery system
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2010520246A5 (el)
BR0211198A (pt) Composições farmacêuticas e seu uso
Kondreddy et al. Effectiveness of a controlled release chlorhexidine chip (PerioCol™-CG) as an adjunctive to scaling and root planing when compared to scaling and root planing alone in the treatment of chronic periodontitis: A comparative study
Rea et al. Clinical and histologic variations among thirty patients with Lucio's phenomenon and pure and primitive diffuse lepromatosis (Latapi's lepromatosis)
EP1852114A4 (en) COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS
EP1243266A4 (en) SOLIDS PREPARATION FOR ORAL APPLICATION
GR1004641B (el) Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα
JP2017520518A (ja) ヒト女性生殖器の外陰部領域を襲う痛みを局所的に治療するためのデバイスおよび製剤
MA27723A1 (fr) Trousse utilisable a des fins pharmaceutiques
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
CO5241355A1 (es) Forma envasada de composiciones farmaceuticas nucleosidicas activas para vacunas contra la hepatitis
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
Einarson et al. Clinical and economic factors in the treatment of onychomycosis